DermTech Inc

OTC Pink - Current Information:DMTKQUnited States

DermTech, Inc. is a molecular diagnostic company. The Company is engaged in developing and marketing non-invasive genomics tests to aid in the diagnosis and management of melanoma. Its technology enhances evaluation of lesions suspicious for melanoma using non-invasive sample collection and detecting genomic markers associated with melanoma to identify higher risk lesions or rule out melanoma with a 99% or higher negative predictive value (NPV). It offers DermTech Melanoma Test (the DMT), which is a non-invasive way to enhance evaluation of pigmented lesions suspicious for melanoma. Its genomics platform has been designed to work with its Smart Sticker, which provides an easy and non-invasive way to collect a skin sample, in contrast to the existing standard of care of using a scalpel to biopsy suspicious lesions. It also provides its research services and technology platform on a contract basis to pharmaceutical companies that use the technology to support their clinical trials.

Contact Information

Headquarters

12340 EL CAMINO REALSAN DIEGO, CA, United States 92130

Phone

858-450-4222

Fax

858-200-3877

Executives

Independent Chairman of the Board

Matthew Posard

President, Chief Executive Officer, Director

Bret Christensen

Chief Financial Officer, Treasurer, Secretary

Kevin Sun

General Counsel

Ray Akhavan

Chief Commercial Officer

Mark Aguillard